ITEMS IN AFP WITH KEYWORD:
In a limited study, children with community-acquired pneumonia who were treated with five days of high-dose amoxicillin had cure rates comparable with those who were treated for 10 days.
An 80-year-old patient presented to the emergency department with several days of increasing shortness of breath and abnormalities on a chest radiograph.
This review found that the best evidence supports C-reactive protein as the most useful and accurate biomarker for diagnosing CAP in adults presenting with lower respiratory tract symptoms.
Lefamulin may be considered for patients hospitalized with community-acquired bacterial pneumonia.
Sep 1, 2020 Issue
Corticosteroids for Hospitalized Patients with Community-Acquired Pneumonia [Cochrane for Clinicians]
For adults hospitalized with severe CAP, the use of corticosteroids may reduce the likelihood of mortality.
The American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) recently updated their recommendations on the diagnosis and treatment of community-acquired pneumonia.
Adding corticosteroid treatment to the management of CAP is beneficial for children and adults. Treatment decreases clinical failures, time in the hospital, and the risk of death in adults with severe pneumonia.
Aug 15, 2019 Issue
Identifying Outpatients with Acute Cough at Very Low Risk of Pneumonia [Point-of-Care Guides]
In patients with acute cough, is it possible to identify a subset with a very low likelihood of community-acquired pneumonia?
When is it safe to treat a patient with community-acquired pneumonia a an outpatient?
The pathogens that cause community-acquired pneumonia are increasingly varied, and common diagnostic methods are unlikely to identify many of them. Clinical suspicion, patient risk factors, and validated scoring systems are available to guide initial management decisions and selection of therapy.